Rivella S - Search Results

1

Combination of a TGF-β ligand trap (RAP-GRL) and TMPRSS6-ASO is superior for correcting β-thalassemia.

Guerra A, Hamilton N, Rivera A, Demsko P, Guo S, Rivella S. Guerra A, et al. Among authors: rivella s. Am J Hematol. 2024 Apr 25. doi: 10.1002/ajh.27332. Online ahead of print. Am J Hematol. 2024. PMID: 38659383

2

Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic Integrations.

Tricoli L, Sase S, Hacker J, Pham V, Smith S, Chappell M, Breda L, Hurwitz S, Tanaka N, Castracani CC, Guerra A, Hou Z, Schlotawa L, Radhakrishnan K, Kurre P, Ahrens-Nicklas R, Adang L, Vanderver A, Rivella S. Tricoli L, et al. Among authors: rivella s. bioRxiv [Preprint]. 2024 Mar 14:2024.03.14.584404. doi: 10.1101/2024.03.14.584404. bioRxiv. 2024. PMID: 38559013 Free PMC article. Preprint.

3

Optimizing lentiviral genomic integrations to cure beta-thalassemia: The least required for success?

Rivella S. Rivella S. Mol Ther Methods Clin Dev. 2024 Mar 5;32(1):101222. doi: 10.1016/j.omtm.2024.101222. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38463140 Free PMC article. No abstract available.

4

Iron restriction in sickle cell disease: When less is more.

Castro OL, De Franceschi L, Ganz T, Kanter J, Kato GJ, Pasricha SR, Rivella S, Wood JC. Castro OL, et al. Among authors: rivella s. Am J Hematol. 2024 Feb 23. doi: 10.1002/ajh.27267. Online ahead of print. Am J Hematol. 2024. PMID: 38400590 Review.

5

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.

Liang R, Lin M, Menon V, Qiu J, Menon A, Breda L, Arif T, Rivella S, Ghaffari S. Liang R, et al. Among authors: rivella s. Blood Adv. 2023 Nov 28;7(22):6873-6885. doi: 10.1182/bloodadvances.2022007655. Blood Adv. 2023. PMID: 37672319 Free PMC article.

6

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis.

Ginzburg Y, An X, Rivella S, Goldfarb A. Ginzburg Y, et al. Among authors: rivella s. Elife. 2023 Aug 14;12:e90189. doi: 10.7554/eLife.90189. Elife. 2023. PMID: 37578340 Free PMC article.

7

In vivo hematopoietic stem cell modification by mRNA delivery.

Breda L, Papp TE, Triebwasser MP, Yadegari A, Fedorky MT, Tanaka N, Abdulmalik O, Pavani G, Wang Y, Grupp SA, Chou ST, Ni H, Mui BL, Tam YK, Weissman D, Rivella S, Parhiz H. Breda L, et al. Among authors: rivella s. Science. 2023 Jul 28;381(6656):436-443. doi: 10.1126/science.ade6967. Epub 2023 Jul 27. Science. 2023. PMID: 37499029

8

Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis.

Guerra A, Parhiz H, Rivella S. Guerra A, et al. Among authors: rivella s. Haematologica. 2023 Oct 1;108(10):2582-2593. doi: 10.3324/haematol.2023.283057. Haematologica. 2023. PMID: 37345473 Free PMC article. Review.

9

Pathogenic Mechanisms in Thalassemia I: Ineffective Erythropoiesis and Hypercoagulability.

Bou-Fakhredin R, Rivella S, Cappellini MD, Taher AT. Bou-Fakhredin R, et al. Among authors: rivella s. Hematol Oncol Clin North Am. 2023 Apr;37(2):341-351. doi: 10.1016/j.hoc.2022.12.005. Hematol Oncol Clin North Am. 2023. PMID: 36907607 Review.

10

Protocol for a high titer of BaEV-Rless pseudotyped lentiviral vector: Focus on syncytium formation and detachment.

Noguchi K, Ikawa Y, Takenaka M, Sakai Y, Fujiki T, Kuroda R, Chappell M, Ghiaccio V, Rivella S, Wada T. Noguchi K, et al. Among authors: rivella s. J Virol Methods. 2023 Apr;314:114689. doi: 10.1016/j.jviromet.2023.114689. Epub 2023 Feb 3. J Virol Methods. 2023. PMID: 36739979 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page